11 December 2025
SOLASTA Bio accelerates path to market with new patents and Asia trial success
SOLASTA Bio now possesses 14 granted patents for our proprietary peptides, including eight in the United States and six in Europe. Building on over 50 greenhouse and field trials, SOLASTA® Bio has broadened its testing program to include critical global staple crops such as rice, alongside ongoing evaluations on high-value leafy greens and soft fruit crops. This expanded trial footprint demonstrates the versatility and adaptability of our peptide-based platform across varied agricultural environments and geographies.
Solasta Bio advances towards market launch with patents and Asia field trial gains | Insider Media: SOLASTA Bio accelerates path to market with new patents and Asia trial success Solasta Bio hails ‘paradigm shift’ in crop protection | The Herald: SOLASTA Bio accelerates path to market with new patents and Asia trial success SOLASTA Bio Accelerates Path to Market With New Patents and Asia Trial Success – AgriBusiness Global: SOLASTA Bio accelerates path to market with new patents and Asia trial success Farming News – SOLASTA® Bio accelerates path to market with new patents and Asia trial success: SOLASTA Bio accelerates path to market with new patents and Asia trial success SOLASTA® Bio Expands Patent Portfolio and Reports Strong Global Field Trial Results: SOLASTA Bio accelerates path to market with new patents and Asia trial success Syngenta rolls out PLINAZOLIN technology across five new insecticides | AgriTech Middle East & Africa – Trends in Investments, Innovation & Sustainability in the Agriculture Industry: SOLASTA Bio accelerates path to market with new patents and Asia trial successMore articles
14 October 2026
SOLASTA Bio attending 3Bio ‘Unlocking Biological Crop Protection’ Expert Conference
SOLASTA Bio's CEO Shireen Davies together with Regulatory and IP colleagues will be attending the 3Bio Expert Conference in Basel, Switzerland immediately after ABIM on the 23rd October. We look ...
14 October 2026
SOLASTA Bio Attending Annual Biocontrol Industry Meeting (ABIM) 2026
SOLASTA Bio's CEO Shireen Davies and Chief Strategy Officer Paula Pinto will be at ABIM 2026 in Basel, Switzerland from 20-22 October. We are looking forward to some stimulating conversations ...